Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study

被引:47
|
作者
Leino, Kari [1 ]
Hynynen, Markku [2 ]
Jalonen, Jouko [1 ]
Salmenpera, Markku [3 ]
Scheinin, Harry [4 ]
Aantaa, Riku [1 ]
机构
[1] Turku Univ Hosp, Dept Anaesthesiol Intens Care Emergency Care & Pa, FIN-20520 Turku, Finland
[2] Jorvi Hosp, Helsinki Univ Hosp, Dept Anesthesia & Intens Care Med, SF-02740 Espoo, Finland
[3] Helsinki Univ Hosp, Dept Anesthesiol & Intens Care, Helsinki, Finland
[4] Univ Turku, Dept Pharmacol, Turku, Finland
来源
BMC ANESTHESIOLOGY | 2011年 / 11卷
关键词
REPLACEMENT THERAPY; AGONISTS; LONG; DETERIORATION; ISOFLURANE; MORTALITY; RISK;
D O I
10.1186/1471-2253-11-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Dexmedetomidine, an alpha(2)-adrenoceptor agonist, has been evaluated as an adjunct to anesthesia and for the delivery of sedation and perioperative hemodynamic stability. It provokes dose-dependent and centrally-mediated sympatholysis. Coronary artery bypass grafting (CABG) with extracorporeal circulation is a stressful procedure increasing sympathetic nervous system activity which could attenuate renal function due the interrelation of sympathetic nervous system, hemodynamics and renal function. We tested the hypothesis that dexmetomidine would improve kidney function in patients undergoing elective CABG during the first two postoperative days. Methods: This was a double-blind, randomized, parallel-group study. Patients with normal renal function and scheduled for elective CABG were randomized to placebo or to infusion of dexmedetomidine to achieve a pseudo steady-state plasma concentration of 0.60 ng/ml. The infusion was started after anesthesia induction and continued until 4 h after surgery. The primary endpoint was creatinine clearance. Other variables included urinary creatinine and output, fractional sodium and potassium excretion, urinary potassium, sodium and glucose, serum and urinary osmolality and plasma catecholamine concentrations. The data were analyzed with repeated-measures ANOVA or Cochran-Mantel-Haenszel test. Results: Sixty-six of 87 randomized patients were evaluable for analysis. No significant between-group differences were recorded for any indices of renal function except for a mean 74% increase in urinary output with dexmedetomidine in the first 4 h after insertion of a urinary catheter (p < 0.001). Confidence interval examination revealed that the sample size was large enough for the no-difference statement for creatinine clearance. Conclusions: Use of intravenous dexmedetomidine did not alter renal function in this cohort of relatively low-risk elective CABG patients but was associated with an increase in urinary output. This study was carried out in 1994-1997 and was thus not registered.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study
    Kari Leino
    Markku Hynynen
    Jouko Jalonen
    Markku Salmenperä
    Harry Scheinin
    Riku Aantaa
    BMC Anesthesiology, 11
  • [2] The effects of dexmedetomidine infusion on renal functions after coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled study
    Goksedef, Deniz
    Balkanay, Ozan Onur
    Omeroglu, Suat Nall
    Talas, Zeki
    Arapi, Berk
    Junusbekov, Yerik
    Sayilgan, Nevzat Cem
    Ipek, Gokhan
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 21 (03): : 594 - 602
  • [3] Myocardial protection during coronary artery bypass graft surgery: A randomized, double-blind, placebo-controlled study with trimetazidine
    Vedrinne, JM
    Vedrinne, C
    Bompard, D
    Lehot, JJ
    Boissel, JP
    Champsaur, G
    ANESTHESIA AND ANALGESIA, 1996, 82 (04): : 712 - 718
  • [4] The effects of dexmedetomidine on thiol/disulphide homeostasis in coronary artery bypass surgery: a randomized controlled trial
    Ozguner, Yusuf
    Altinsoy, Savas
    Kulturoglu, Gokcen
    Unal, Dilek
    Ergil, Julide
    Neselioglu, Salim
    Erel, Ozcan
    BMC ANESTHESIOLOGY, 2024, 24 (01):
  • [5] Randomized, Placebo-Controlled Study on the Effects of Dexmedetomidine on Pain in Patients Undergoing Elective Spinal Surgery
    Doan, Lisa
    Franco, Lola
    Commeh, Ekow
    Cuff, Germaine
    Wang, Jing
    Denatale, Christopher
    Ard, John
    ANESTHESIA AND ANALGESIA, 2023, 136 : 656 - 656
  • [6] Effect of dexmedetomidine on intracranial pressures during laparoscopic surgery: A randomized, placebo-controlled trial
    Sahay, Nishant
    Bhadani, Umesh K.
    Guha, Subhajit
    Himanshu, Alok
    Sinha, Chandni
    Bara, Mamta
    Sahay, Anubha
    Ranjan, Alok
    Singh, Prashant
    JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2018, 34 (03) : 341 - 346
  • [7] Dexmedetomidine during coronary artery bypass grafting surgery:: is it neuroprotective?: -: A preliminary study
    Sulemanji, D. S.
    Donmez, A.
    Aldemir, D.
    Sezgin, A.
    Turkoglu, S.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2007, 51 (08) : 1093 - 1098
  • [8] Effects of preoperative aspirin in coronary artery bypass grafting: A double-blind, placebo-controlled, randomized trial
    Deja, Marek A.
    Kargul, Tomasz
    Domaradzki, Wojciech
    Stacel, Tomasz
    Mazur, Witold
    Wojakowski, Wojciech
    Gocol, Radoslaw
    Gaszewska-Zurek, Ewa
    Zurek, Pawel
    Pytel, Agata
    Wos, Stanislaw
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (01): : 204 - +
  • [9] The dose-related effects of Dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study
    Balkanay, Ozan Onur
    Goksedef, Deniz
    Omeroglu, Suat Nail
    Ipek, Gokhan
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2015, 20 (02) : 209 - 214
  • [10] Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery - A randomized, double-blind, placebo-controlled trial
    BennettGuerrero, E
    Jimenez, JL
    White, WD
    DAmico, EB
    Baldwin, BI
    Schwinn, DA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (09): : 687 - 692